J&J Unit Must Pay $147 Million in Catheter Lawsuit, Jury Finds

A federal jury found that Johnson & Johnson unit Biosense Webster Inc. broke federal and state antitrust laws by monopolizing the nationwide market for heart-mapping catheters and ordered it to pay more than $147 million in damages to a rival.

The jury on May 16 determined that catheter reseller Innovative Health LLC proved Biosense violated Section 1 of the Sherman Act by illegally tying its catheters to its cardiac mapping machine, CARTO 3, said Joshua P. Davis, a Berger Montague attorney who represents Innovative.

Biosense was also found in violation of Section 2 of the Sherman Act through its monopolization ...